NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- Death of Cannulation Expert, Educator and Home Dialysis Champion, Stuart Mott Posted 07-12-2024
- PD and Home HD Sessions and Posters from the 2024 NKF Spring Clinicals Posted 06-14-2024
- New, Validated Survey of Home Dialysis Patients’ Experience of Care Posted 06-14-2024
- Baxter Launches MyPD Digital Management App in Korea Posted 06-14-2024